Eye injections are a highly effective treatment for several severe retinal and macular conditions. From age-related macular degeneration (AMD) to diabetic retinopathy and retinal vein occlusion, intravitreal injections help control disease progression, preserve vision, and sometimes even restore sight. These injections deliver medication directly into the eye, ensuring fast and targeted results with minimal systemic side effects.
The cost of eye injections in India ranges from $100 to $400 per injection (approximately ₹8,000 to ₹35,000), depending on the drug used and the condition being treated. The pricing is significantly more affordable than in countries like the USA or UK, where a single injection may cost over $1,500. In India, top eye hospitals and retina specialists offer access to the same global-standard medications—such as Avastin, Lucentis, Eylea, and Ozurdex—at a fraction of the cost.
Eye injections, medically known as intravitreal injections, are procedures used to deliver medication directly into the vitreous cavity—the gel-like substance inside the eye. This method ensures that the drug reaches the retina and macula with maximum effectiveness, which is crucial in treating vision-threatening conditions.
Unlike oral medications or eye drops, these injections bypass barriers in the eye and allow for a highly localized therapeutic effect, reducing damage and inflammation at the retinal level. They are typically administered in a sterile setting by a retinal specialist and take only a few minutes to complete.
The most common classes of medication injected into the eye include:
Patients may require a single injection or a series of treatments administered over several months, depending on the diagnosis and the severity of the disease. In many cases, eye injections have become the gold standard for saving sight, offering hope where once vision loss was inevitable.
Eye injections play a critical role in managing a wide range of retinal and ocular diseases, particularly those that threaten central vision or cause progressive damage. These conditions often involve leakage, swelling, inflammation, or the growth of abnormal blood vessels in or around the retina.
Some of the most common conditions effectively treated with intravitreal injections are:
Many patients feel anxious before their first eye injection, but the procedure is surprisingly quick, safe, and mostly painless. Knowing the step-by-step process can help ease concerns and prepare you for what’s ahead.
The cost of an eye injection can vary significantly depending on the condition being treated, drug used, and the facility where the procedure is performed. In India, the average cost of an intravitreal eye injection ranges from $100 to $400 (₹8,000 to ₹35,000) per injection. It includes both the drug and the professional services required to administer it safely.
The total cost of eye injections varies primarily based on the medication used. Each drug is selected based on the severity of the condition, the patient's response to previous treatments, and the drug's cost-effectiveness. While some medications offer long-lasting effects, others may require more frequent dosing.
|
Drug Name |
Type of Medication |
Common Uses |
Cost in India (USD) |
|
Avastin (Bevacizumab) |
Anti-VEGF (Off-label) |
Diabetic Retinopathy, Wet AMD |
$100 – $150 |
|
Lucentis (Ranibizumab) |
Anti-VEGF |
Wet AMD, Macular Edema, Retinal Vein Occlusion |
$300 – $400 |
|
Eylea (Aflibercept) |
Anti-VEGF |
Macular Edema, Wet AMD, Diabetic Macular Edema |
$350 – $450 |
|
Ozurdex (Dexamethasone) |
Steroid Implant |
Uveitis, Macular Edema, Postoperative Inflammation |
$400 – $500 |
|
Triamcinolone Acetonide |
Corticosteroid |
Diabetic Macular Edema, Retinal Swelling |
$100 – $200 |
When comparing international healthcare costs, India continues to offer some of the most affordable options for eye injections, without compromising on quality, safety, or access to global-standard drugs. Patients from the US, UK, UAE, and Africa often travel to India to receive the same medications and expert care at a fraction of the cost.
|
Drug Name |
India |
USA |
UK |
UAE |
South Africa |
|
Avastin (Bevacizumab) |
$100 – $150 |
$800 – $1,200 |
$600 – $950 |
$700 – $1,000 |
$500 – $900 |
|
Lucentis (Ranibizumab) |
$300 – $400 |
$1,500 – $2,000 |
$1,200 – $1,600 |
$1,300 – $1,700 |
$1,000 – $1,400 |
|
Eylea (Aflibercept) |
$350 – $450 |
$1,800 – $2,400 |
$1,400 – $1,900 |
$1,600 – $2,000 |
$1,200 – $1,600 |
|
Ozurdex (Dexamethasone) |
$400 – $500 |
$2,000 – $2,500 |
$1,500 – $2,100 |
$1,800 – $2,300 |
$1,300 – $1,800 |
|
Triamcinolone Acetonide |
$100 – $200 |
$400 – $700 |
$300 – $600 |
$350 – $700 |
$250 – $500 |
This significant cost difference is one of the primary reasons India remains a preferred destination for retinal care among medical travelers.
India has emerged as a top destination for advanced eye care, particularly for patients requiring intravitreal injections. Here’s why international patients increasingly prefer India for vision-saving treatments:
Eye injections are typically performed as outpatient procedures, allowing patients to go home shortly after treatment. However, proper aftercare and follow-up are crucial to ensure healing, monitor progress, and prevent complications.
Eye injections are considered very safe when performed by trained specialists, but like any medical procedure, they carry some potential side effects and risks. Fortunately, most side effects are mild and short-lived. Serious complications are rare but should be promptly addressed if they occur.
Many patients experience temporary discomfort or visual disturbances after the injection. These are typically not a cause for concern and resolve on their own:
These occur occasionally and usually require follow-up care:
Though extremely rare (less than 1 in 1000), the following risks require immediate medical attention:
You should contact your eye doctor right away if you notice:
Eye injections are commonly used to treat retinal diseases, including diabetic retinopathy, macular edema, wet age-related macular degeneration (AMD), retinal vein occlusion, and uveitis.
While eye injections may not reverse permanent vision loss, they can stabilize or improve vision by reducing fluid buildup, bleeding, or inflammation in the retina.
Anti-VEGF injections reduce abnormal blood vessel growth and leakage in the retina, helping control swelling and prevent further vision deterioration in diabetic patients.
Eye injections are not typically the first-line treatment for glaucoma but may be used in specific cases of inflammatory glaucoma or post-surgical complications.
Not all eye bleeding needs an injection. Minor surface bleeds (subconjunctival hemorrhage) often heal on their own, while internal bleeding like vitreous hemorrhage may require intravitreal treatment.
No, eye injections are generally not painful. The eye is numbed with anesthetic drops before the procedure, so most patients feel only mild pressure or no sensation at all.
The entire procedure takes about 10–15 minutes, with the injection itself lasting less than 10 seconds.
The frequency depends on your condition and the drug used. Some patients need monthly injections, while others may require them every 6–8 weeks or less frequently.
After an injection, avoid rubbing your eyes, swimming, and exposing your eyes to dust and dirty water for at least 24–48 hours. Follow your doctor’s aftercare instructions closely.
Yes, in some cases where both eyes require treatment, injections may be administered to both eyes during the same visit under strict sterile conditions.
The average cost of an eye injection in India ranges from $100 to $500 per injection, depending on the drug used—such as Avastin, Lucentis, Eylea, or Ozurdex.
India offers significantly lower costs due to subsidized healthcare services, local availability of medications, and competitive pricing without compromising treatment quality.
Yes, most reputable hospitals in India offer comprehensive support for international patients, including visa assistance, airport pickup, accommodation assistance, and dedicated patient coordinators.